On October 14, CANSINOBIO fell 5.08% in regular trading, with shares at HK$29.9 and turnover of HK$84.08 million.

The most recent company-specific update was its disclosure that it received a government subsidy of RMB2.8663 million, recognized in current profit or loss. The company said the amount equaled 10.28% of its latest audited annual net profit and is expected to have a positive effect on profit, although the final accounting impact remains subject to the annual audit.

However, the stock's decline appears to be occurring against a weaker biotechnology backdrop rather than on that announcement alone. Among sector names, AKESO fell 10.19%, INNOVENT BIO fell 4.08%, BEONE MEDICINES fell 2.24%, SKB BIO fell 2.67%, and 3SBIO fell 2.37%.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)